Epidemiology and etiology of multiple sclerosis

John F Kurtzke1

  • 1Neurology Service, Veterans Affairs Medical Center, Washington, DC, USA. kurtzke2@aol.com

Insights

A widespread infection, primary multiple sclerosis affection (PMSA), may cause clinical neurologic multiple sclerosis (CNMS) years later. Susceptibility is limited to ages 11-45, with transmission occurring between ages 13-26.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Epidemiology

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease with an unknown etiology.
  • The Faroese saga is proposed as a unique historical dataset to investigate MS origins.
  • A hypothesis suggests a transmissible infectious agent as the cause of MS.

Purpose of the Study:

  • To propose a novel hypothesis for the etiology of Multiple Sclerosis (MS).
  • To identify a potential infectious agent, termed primary multiple sclerosis affection (PMSA), as the cause of MS.
  • To explore the transmission dynamics and susceptibility window for PMSA.

Main Methods:

  • The study is theoretical, based on the interpretation of historical data (Faroese saga).
  • It posits the existence of an unidentified, persistent, and transmissible infection (PMSA).
  • It infers the presence of PMSA from the observed incidence of clinical neurologic multiple sclerosis (CNMS).

Main Results:

  • PMSA is hypothesized as a widespread, persistent infection transmitted person-to-person.
  • A small fraction of individuals with PMSA develop CNMS years later.
  • Susceptibility to PMSA is age-limited (approx. 11-45 years), with transmission occurring during a specific window (approx. 13-26 years on Faroe Islands).

Conclusions:

  • CNMS is not directly transmissible, but its existence suggests prior PMSA infection.
  • The proposed model offers a new perspective on MS pathogenesis, emphasizing an infectious origin.
  • Further research is needed to identify PMSA and validate its role in MS development.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.